Lifespan's A - Z Health Information Library - Serum sickness(Site not responding. Last check: 2007-11-06)
Serum sickness is a group of symptoms caused by a delayed immune response to certain medications or antiserum (passive immunization with antibodies from an animal or another person).
Antiserum is a preparation of serum that has been removed from a person or animal that has already developed immunity to a particular microorganism.
An injection of antiserum (passive immunization) may be used when a person has been exposed to a potentially dangerous microorganism against which the person has not been immunized.
In an effort to decrease deaths from gram-negative bacteremia and endotoxin shock, we treated bacteremic patients with human antiserum to endotoxin (lipopolysaccharide) core.
Antiserum was prepared by vaccinating healthy men with heat-killed Escherichia coli J5; this mutant lacks lipopolysaccharide oligosaccharide side chains, so that the core, which is nearly identical to that of most other gram-negative bacteria, is exposed for antibody formation.
In a randomized controlled trial, patients were given either J5 antiserum or preimmune control serum intravenously, near the onset of illness.
A 1/400 dilution of rabbit antiserum was incubated
Radiolabelled virus was bound to RD cells pre-treated with media alone (None), polyclonal rabbit anti-CD59 antiserum at 1:100 (Anti-CD59) or the anti-DAF MAb 854 at 1:1000 (Anti-DAF) for 1 h at 4 °C. Virus was allowed to adsorb for 1 h at 4 °C, the unbound virus removed and the cell-associated virus quantified by scintillation counting.
RD cells were treated with media alone (mock) or anti-CD59 antiserum (1:100) for 1 h at 37 °C and radiolabelled virus bound to cells at 4 °C either in the presence or absence of the antiserum.
Urinary and plasma urodilatin measured by a direct RIA using a highly specific antiserum -- Meyer et al.
Antiserum S70/94 was used in a final dilution of 1:240 000 in
Comparison of URO concentrations in 32 urine samples as determined by the present RIA, using sheep antibody S70/94, and the RIA by the method of Drummer et al.
of the secondary antiserum, diluted with 3.5% polyethylene glycol
Immunoreactivity of the pituitaries of several animals to ST-7 antiserum.
Tanaka S, Park MK, Hayashi H, Hanaoka Y, Wakabayashi K, Kurosumi K (1990) Immunocytochemical localization of the subunit of glycoprotein hormones (LH, FSH and TSH) in the bullfrog pituitary gland using monoclonal antibodies and polyclonal antiserum.
Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors -- Toller et al.
Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors
antiserum was probed on the crude membrane fractions of tumors.
Difco™ Bordetella Pertussis Antiserum and Difco Bordetella Parapertussis Antiserum are recommended for use in slide agglutination tests for the identification of Bordetella pertussis and Bordetella parapertussis.
It is recommended that the user refer to pertinent NCCLS guidance and CLIA regulations for appropriate Quality Control practices.
Difco Bordetella Pertussis Antiserum and Difco Bordetella Parapertussis Antiserum are lyophilized, polyclonal rabbit antisera containing approximately 0.04% thimerosal as a preservative.
Blots of serotype 1/2a strain J0098 (A), serotype 4b strain J0097 (B), or a mixture of strains J0098 and J0097 (C) were probed sequentially with O-factor antiserum I/II (stained red) and O-factor antiserum V/VI (stained green).
(D) A streak plate of strain 19118 was blotted and probed sequentially with O-factor antiserum V/VI (stained red) and O-factor antiserum I/II (stained green).
Polyclonal Antiserum to Human C1 Inhibitor (C1 Esterase)*
Polyclonal Antiserum to Human Factor B* Polyclonal Antiserum to Human Factor I* Polyclonal Antiserum to Human Factor H* Quidel Bb EIA Kit *
Our goal is to deliver first-to-market products that provide a specialized value-added benefit of lowering overall healthcare costs and improving the quality of healthcare today.
